MLTX
Price
$42.33
Change
+$0.23 (+0.55%)
Updated
Feb 21 closing price
Capitalization
2.67B
29 days until earnings call
RGNX
Price
$7.27
Change
-$0.09 (-1.22%)
Updated
Feb 21 closing price
Capitalization
360.19M
9 days until earnings call
Ad is loading...

MLTX vs RGNX

Header iconMLTX vs RGNX Comparison
Open Charts MLTX vs RGNXBanner chart's image
MoonLake Immunotherapeutics
Price$42.33
Change+$0.23 (+0.55%)
Volume$225.28K
Capitalization2.67B
REGENXBIO
Price$7.27
Change-$0.09 (-1.22%)
Volume$632.91K
Capitalization360.19M
MLTX vs RGNX Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. RGNX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and RGNX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (MLTX: $42.33 vs. RGNX: $7.27)
Brand notoriety: MLTX and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 59% vs. RGNX: 51%
Market capitalization -- MLTX: $2.67B vs. RGNX: $360.19M
MLTX [@Biotechnology] is valued at $2.67B. RGNX’s [@Biotechnology] market capitalization is $360.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 2 bullish TA indicator(s).

  • MLTX’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than RGNX.

Price Growth

MLTX (@Biotechnology) experienced а -2.04% price change this week, while RGNX (@Biotechnology) price change was -0.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

MLTX is expected to report earnings on May 08, 2025.

RGNX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.67B) has a higher market cap than RGNX($360M). RGNX YTD gains are higher at: -5.951 vs. MLTX (-21.828). MLTX has higher annual earnings (EBITDA): -108.45M vs. RGNX (-217.82M). MLTX has more cash in the bank: 494M vs. RGNX (255M). MLTX has less debt than RGNX: MLTX (3.69M) vs RGNX (84.1M). RGNX has higher revenues than MLTX: RGNX (84.3M) vs MLTX (0).
MLTXRGNXMLTX / RGNX
Capitalization2.67B360M741%
EBITDA-108.45M-217.82M50%
Gain YTD-21.828-5.951367%
P/E RatioN/AN/A-
Revenue084.3M-
Total Cash494M255M194%
Total Debt3.69M84.1M4%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXRGNX
RSI
ODDS (%)
Bullish Trend 4 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 24 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AZMCX16.850.32
+1.94%
Virtus NFJ Emerging Markets Value C
JMIEX32.44-0.23
-0.70%
JPMorgan Emerging Markets Equity L
GABIX46.99-0.63
-1.32%
Gabelli Asset I
JIVZX30.28-0.41
-1.34%
JPMorgan U.S. Applied Data Sci Val R2
GCVUX23.93-0.37
-1.52%
Goldman Sachs Large Cp Val Insghts R6

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.55%
XENE - MLTX
37%
Loosely correlated
+0.89%
RGNX - MLTX
37%
Loosely correlated
-1.22%
AKBA - MLTX
36%
Loosely correlated
-5.76%
MIST - MLTX
36%
Loosely correlated
-0.97%
CRNX - MLTX
36%
Loosely correlated
+1.63%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-1.22%
BEAM - RGNX
50%
Loosely correlated
-8.18%
DNLI - RGNX
49%
Loosely correlated
-3.98%
AXON - RGNX
48%
Loosely correlated
-5.28%
RCKT - RGNX
48%
Loosely correlated
-3.68%
NTLA - RGNX
46%
Loosely correlated
-0.65%
More